Cardio Diagnostics Holdings, Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | — | $14.8K | $34.9K | $17.1K | $950 | $901 |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| Operating Expenses | ||||||
| Research & Development | — | $641.2K | $228.0K | $145.2K | $40.4K | $31.5K |
| SG&A Expense | — | $5.0M | $6.9M | $6.9M | $4.4M | $470.6K |
| Operating Income | — | $-6.5M | $-8.4M | $-7.2M | $-4.5M | $-620.4K |
| Operating Margin | — | -43,737.5% | -23,977.9% | -42,440.4% | -478,784.3% | -68,862.2% |
| Interest Expense | — | $14.8K | $18.6K | $6.7M | — | — |
| Pretax Income | — | $-6.5M | $-8.4M | $-8.4M | $-4.7M | $-620.4K |
| Income Tax Expense | — | — | — | — | $0 | $0 |
| Net Income | — | $-6.5M | $-8.4M | $-8.4M | $-4.7M | $-620.4K |
| Net Margin | — | -43,832.5% | -24,028.2% | -49,087.8% | -490,630.0% | -68,862.2% |
| EPS (Basic) | — | $-3.71 | $-9.35 | $-0.66 | $-0.38 | $-0.04 |
| EPS (Diluted) | — | $-3.71 | $-9.35 | $-0.66 | $-0.38 | $-0.04 |
| Shares Outstanding (Basic) | 3.0M | 1.8M | 896.4K | 12.7M | 12.4M | 14.0M |
| Shares Outstanding (Diluted) | 3.0M | 1.8M | 896.4K | 12.7M | 12.4M | 14.0M |
| Dividends Per Share | — | — | — | — | — | — |